Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
TERM | SPECIFICATION | TEST METHOD |
Appearance | Fine powder | Visua |
Color | Yellowish | Visual |
Odor | Characteristic | Sensory |
Taste | Characteristic | Sensory |
Physical&Chemica | ||
dentification | Complies to the standard | TLC |
Sulforaphane | ≥1.0% | HPLC |
Particle size | NLT 95%through 80mesh | USP38<786> |
Bulk density | 0.35~0.55g/ml | USP38<616> |
Tapped density | 0.45~0.65g/ml | USP38<616> |
Loss on drying | ≤5.0% | USP38<731> |
Total Ash | ≤5.0% | USP38<561> |
Residual solvents | Meets USP requirements | USP38<476> |
Pesticides | Meets USP requirements | USP38<561> |
Aflatoxins | Meets USP requirements | USP38<561> |
Heavy metal Profile | ||
Heavy meta | <10ppm | A AS |
Pb | <1ppm | A AS |
As | <1ppm | A AS |
Hg | <0.1ppm | A AS |
Cd | <1ppm | A AS |
Microbiological profile: | ||
Total plate count | <1000Cfu/g | GB 4789.2 |
Yeasts and molds | <100Cfu/g | GB4789.15 |
Coliforms | Negative/g | GB 4789.3 |
E.coli | Negative/g | GB4789.38 |
Salmonella | Negative/25g | GB 4789.4 |
Staphylococcus aureus | Negative/10g | GB4789.10 |
1. Antioxidation and detoxification
• Nrf2 pathway activation: induces glutathione (GSH) synthase (GCL) expression, increases intracellular GSH level by 300-500%.
• Heavy metal chelation: binds heavy metals such as arsenic and cad mium to promote bile excretion
2. Anti-inflammatory and immunomodulatory
• Inhibits NF-κB: reduces pro-inflammatory factors such as IL-6 and TNF-α
• Enhances NK cell activity: enhances the immune surveillance ability of cancer models
3. Anti-cancer and epigenetic regulation
• Histone deacetylase (HDAC) inhibition: restores tumor suppressor gene expression and induces cancer cell apoptosis.
• Breast cancer prevention: downregulates estrogen metabolic toxicity product 4-OH-E2
4. Neuroprotection and metabolic health
• Blood-brain barrier penetration: reduces β-amyloid protein deposition
Fasting blood glucose in diabetic models decreased by 18%